[ Price : $8.95]
Endo International withdraws its supplemental NDA seeking specific abuse deterrent labeling for Opana ER (oxymorphone HCl extended...[ Price : $8.95]
FDA announces a 9/25 public workshop on Facilitating Anti-infective Drug Development for Neonates and Young Infants to discuss the...[ Price : $8.95]
Federal Register Notice: FDA issues a revised draft guidance: Dietary Supplements: New Dietary Ingredient Notifications and Relate...[ Price : $8.95]
FDA posts two final guidances on electrosurgical device 510(k) submissions.[ Price : $8.95]
BioMerieux recalls its NucliSENS easyMAG Magnetic Silica because of effects on nucleic acids extraction performance.[ Price : $8.95]
The Clinical Trials Transformation Initiative releases new recommendations to streamline antibacterial drug development to treat h...[ Price : $8.95]
Attorney Mark Schwartz says FDA is finally taking steps to address the fact that it has not had an objective measure of drug quali...[ Price : $8.95]
FDA issues a draft guidance on premarket safety notifications for new dietary ingredients.